Narrow Results Clear All
- Communication Improvement 2
- Culture of Safety 1
- Error Reporting and Analysis 4
- Human Factors Engineering 4
- Legal and Policy Approaches 3
- Quality Improvement Strategies 3
- Technologic Approaches 2
- Drug shortages 1
- Identification Errors 1
- Medication Safety 13
- Surgical Complications 1
- Transfusion Complications 1
Search results for "Press Release/Announcement"
Differences in strength expression on product labels of compounders and conventional manufacturers may lead to dosing errors.
Silver Spring, MD: US Food and Drug Administration; September 29, 2018.
Safe handling of concentrated electrolyte products from outsourcing facilities during critical drug shortages.
National Alert Network. Horsham, PA: Institute for Safe Medication Practices; Bethesda, MD: American Society of Health-System Pharmacists. May 24, 2018.
Drug shortages can necessitate hospitals to find alternative sources for important medications. This alert raises awareness of risks associated with potassium chloride use due to variations in labeling, packaging, or concentration of outsourced medications. Recommendations include use of barcode scanning and communicating with staff regarding drug shortages.
Warning! Severe burns and permanent scarring after glacial acetic acid (≥99.5%) mistakenly applied topically.
National Alert Network for Serious Medication Errors. Bethesda, MD: American Society of Health-System Pharmacists and Institute for Safe Medication Practices; January 23, 2013.
Describing several incidents of a corrosive chemical mistakenly applied to skin that led to severe burns and scarring, this alert recommends steps to prevent such errors.
Hospira Carpuject pre-filled cartridges—drug alert: products may contain more than the intended fill volume.
MedWatch Safety Alert. Silver Spring, MD: US Food and Drug Administration; May 23, 2012.
This announcement raises awareness of pre-filled medication cartridges that may be overfilled, thereby increasing the risk of overdose. The FDA recommends that practitioners confirm the dosage prior to dispensing and administering the medication.
Institute for Safe Medication Practices and Institute for Safe Medication Practices Canada.
This tool evaluates the safety of cancer treatment delivery in hospitals and ambulatory care settings.
MedWatch Safety Alert, FDA Drug Safety Communication. Silver Spring, MD: US Food and Drug Administration; June 13, 2011.
This notice raises awareness of a two look-alike/sound-alike drugs, one an antipsychotic medication and the other a dopamine agonist.
MedWatch Safety Alert. Silver Spring, MD: US Food and Drug Administration; December 9, 2008.
This announcement recalls a particular lot of injectable potassium chloride solution due to incorrect barcode labeling, which could result in medication errors.
MedWatch Safety Alert. Silver Spring, MD: US Food and Drug Administration; January 18, 2008.
This announcement provides information on a recall of heparin vials due to negative reactions reported with certain batches of the medication.
Silver Spring, MD: American Nurses Association; June 18, 2007.
The American Nurses Association announces the results from a survey of more than 1000 nurses on medication error and syringe safety.
Roxane Laboratories Initiates a Nationwide Voluntary Recall of a Single Manufacturing Lot of Azathioprine Tablets in the U.S. and Puerto Rico.
MedWatch Safety Alert. Silver Spring, MD: US Food and Drug Administration; July 13, 2006.
This news release announces the recall of a manufacturing lot of Azathioprine. Bottles may have been erroneously filled with another medication, which could lead to serious health effects for those taking the drug.
Baltimore, MD: Centers for Medicare & Medicaid Services (CMS) Office of Public Affairs; May 18, 2006.
This fact sheet provides information regarding the Centers for Medicare and Medicaid Services' initiative to better understand and minimize never events.
FDA Alert [US Food and Drug Administration Web site]. April 25, 2006.
This alert highlights the dangers of administering promethazine hydrochloride to young children and includes information sheets for both patients and health care professionals.
The John D. and Catherine T. MacArthur Foundation. September 20, 2005.
Michael Cohen, President of the Institute for Safe Medication Practices, has focused his career on preventing medical errors with innovative and elegant solutions. The MacArthur Foundation has selected him as a 2005 Fellow and recipient of a $500,000 "genius grant."